Category: Disease Discoveries
-
Transcription Factor Responsible for Variability in Congenital Brain Disorder
Northwestern Medicine scientists have identified one of the molecular mechanisms behind the variability of holoprosencephaly, a congenital brain malformation.
-
Astrocytes May Play a Role in Parkinson’s Disease
New Northwestern Medicine research shows how astrocytes, a type of cell in the brain, may play a role in regulating a pathway that is overactive in Parkinson’s disease.
-
New Insights Into Mechanisms Behind Polycystic Kidney Disease
A new study shows potential mechanisms leading to the activation of a mutated gene in autosomal dominant polycystic kidney disease.
-
Investigating the Molecular Roots of Lung Disease
Chief Scott Budinger, MD, and the other scientists in Pulmonary and Critical Care Medicine tackle some of the most common — and fatal — medical conditions in the world.
-
Potential Target for Treating Severe Malaria Identified
A pair of proteins that promote blood vessel formation are associated with the development of severe malaria, and they may be a target for future therapeutics, according to recent research.
-
Enzyme Identified as Target Against Triple-Negative Breast Cancer
Northwestern Medicine scientists identified an enzyme as a potential new target for triple-negative breast cancer, a form of breast cancer that is associated with early tumor recurrence and significantly increased mortality rates.
-
Pinpointing the Origins of Prostate Cancer
Northwestern Medicine scientists have identified a protein that acts as a marker for a population of cells that may be an origin for prostate cancers.
-
A New Method to Predict Damage in Transplanted Kidneys
A Northwestern Medicine study has identified a gene set that can predict whether a transplanted kidney is at risk of damage and subsequent loss.
-
Understanding Signaling Pathways in Brain Tumors
Northwestern Medicine scientists have identified a signaling pathway that regulates the behavior of two subtypes of glioblastomas.
-
Scientists Find New Path in Brain to Ease Depression
A new pathway in the brain can be manipulated to alleviate depression, offering a promising new target for developing a drug that could be effective in individuals for whom other antidepressants have failed.
